https://clarivate.com/life-sciences-healthcare/report/unnecg0039-2025-biopharma-multiple-sclerosis-unmet-need-unmet-need-multiple-sclerosis-nonrelapsing-secondary/
Multiple Sclerosis - Unmet Need - Unmet Need - Multiple Sclerosis: Nonrelapsing...
No treatments are approved for nonrelapsing secondary-progressive multiple sclerosis (nrSP-MS), an MS disease course in which physical disability accumulates...
multiple sclerosisunmet need